Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm', 'dlbcl']
longer follow up needed for #glofitamab in dlbcl #lymsm , but seems patients with cr maintain the remission for now #ash22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.